The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Safety of Withholding Heparin in Pregnant Women with a History of Venous Thromboembolism
Open accessAbstract
BACKGROUND: Women with a history of venous thromboembolism may be at increased risk for venous thromboembolic events during pregnancy. In these women, the decision to give or withhold heparin in the antepartum period is controversial, because accurate estimates of the frequency of recurrent thromboembolic events if antepartum heparin is withheld are not available. METHODS: We prospectively studied 125 pregnant women with a single previous episode of venous thromboembolism. Antepartum heparin was withheld, but anticoagulant therapy was given for four to six weeks post partum. Our primary objective was to determine the rate of antepartum recurrence of venous thromboembolism. Laboratory studies were performed to identify thrombophilia in 95 women. RESULTS: Three of the 125 women (2.4 percent) had an antepartum recurrence of venous thromboembolism (95 percent confidence interval, 0.2 to 6.9 percent). There were no recurrences in the 44 women who had no evidence of thrombophilia and who also had a previous episode of thrombosis that was associated with a temporary risk factor. Among the 51 women with abnormal laboratory results or a previous episode of idiopathic thrombosis, or both, 3 (5.9 percent) had an antepartum recurrence of venous thromboembolism (95 percent confidence interval, 1.2 to 16.2 percent). CONCLUSIONS: The risk of recurrent antepartum venous thromboembolism in women with a history of venous thromboembolism is low, and therefore routine antepartum prophylaxis with heparin is not warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,783
Poort, Sr., Rosendaal, F., Reitsma, P., & Bertina, R. (1996) · Blood · doi:10.1182/blood.v88.10.3698.bloodjournal88103698 · Cited by 3,079
Anderson, F. A. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400050081016 · Cited by 1,669
Proctor, R. R., & Rapaport, S. I. (1961) · American Journal of Clinical Pathology · doi:10.1093/ajcp/36.3.212 · Cited by 980
Schulman, S., Rhedin, A.-S., Lindmarker, P., Carlsson, A., Lärfars, G., Nicol, P., Loogna, E., Svensson, E., Ljungberg, B., Walter, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322501 · Cited by 932
Detection of Deep-Vein Thrombosis by Real-Time B-Mode Ultrasonography
Lensing, A. W. A., Prandoni, P., Brandjes, D., Huisman, P. M., Vigo, M., Tomasella, G., Krekt, J., ten Cate, J. W., Huisman, M. V., & Büller, H. R. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200602 · Cited by 875
Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic Cancer
Prandoni, P., Lensing, A. W. A., Büller, H. R., Cogo, A., Prins, M. H., Cattelan, A. M., Cuppini, S., Noventa, F., & ten Cate, J. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210153271604 · Cited by 680
Use of Antithrombotic Agents During Pregnancy
Ginsberg, J. S., & Hirsh, J. (1995) · Chest · doi:10.1378/chest.108.4_supplement.305s · Cited by 657
Self-citationRisk of Fatal Pulmonary Embolism in Patients With Treated Venous Thromboembolism
Douketis, J. D. (1998) · JAMA · doi:10.1001/jama.279.6.458 · Cited by 617
O'Neill, D. D., Westerman, D. P., & Sacco, W. (1966) · doi:10.21236/ad0635168 · Cited by 566
Loizou, S., McCrea, J. D., Rudge, A. C., Reynolds, R., Boyle, C. C., & Harris, E. N. (1985) · PubMed Central · Cited by 549
The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants
Thiagarajan, P., Pengo, V, & Shapiro, S. (1986) · Blood · doi:10.1182/blood.v68.4.869.869 · Cited by 422
Causes of maternal mortality in the United States.
Kaunitz, A., Hughes, J. M., Grimes, D. A., Smith, J. C., Rochat, R. W., & Kafrissen, M. E. (1985) · PubMed · Cited by 384
Dahlman, T. C. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90378-v · Cited by 379
Levine, M. N., Hirsh, J., Gent, M., Turpie, A. G., Weitz, J., Ginsberg, J., Geerts, W., LeClerc, J., Neemeh, J., Powers, P., et al. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649783 · Cited by 353
Self-citationRecurrence of Venous Thromtoembolic Disease and Use of Oral Contraceptives
Badaracco, M. A., & Vessey, M. P. (1974) · BMJ · doi:10.1136/bmj.1.5901.215 · Cited by 161
Maternal Mortality in Massachusetts
Sachs, B. P., Brown, D. A. J., Driscoll, S. G., Schulman, E., Acker, D., Ransil, B. J., & Jewett, J. F. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703123161105 · Cited by 160
The risks of antenatal subcutaneous heparin prophylaxis: a controlled trial
Howell, R. J. S., Fidler, J., Letsky, E. A., & de Swiet, M. (1983) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1983.tb06458.x · Cited by 153
Changes in protein C and protein S levels in normal pregnancy
Faught, W., Garner, P. R., Jones, G., & Ivey, B. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90104-3 · Cited by 134
A Hexagonal (II) Phase Phospholipid Neutralization Assay for Lupus Anticoagulant Identification
Triplett, D. A., Barna, L. K., & Unger, G. A. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649671 · Cited by 129
Recurrent thromboembolism in pregnancy and puerperium
Tengborn, L., Bergqvist, D., Mätzsch, T., Bergqvist, A., & Hedner, U. K. E. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90095-1 · Cited by 126
Osteopenia in pregnancy during long‐term heparin treatment: A radiological study post partum
Dahlman, T. C., Lindvall, N., & Hellgren, M. (1990) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1990.tb01785.x · Cited by 113
Use of Antithrombotic Agents During Pregnancy
Ginsberg, J. S., & Hirsh, J. (1998) · CHEST Journal · doi:10.1378/chest.114.5_supplement.524s · Cited by 101
Self-citationColvin, B. T., & Barrowcliffe, T. W. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.2.97 · Cited by 74
Prophylaxis of thromboembolism in pregnancy: an alternative
Lao, T. T. H., de Swiet, M., Letsky, E. A., & Walters, B. N. J. (1985) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1985.tb01082.x · Cited by 62
Low risk of recurrent thromboembolism in pregnancy.
de Swiet, M., Floyd, E., & Letsky, E. A. (1987) · PubMed · Cited by 49
Colvin, B., Letsky, E., Rivers, R. P., Stevens, R. P., Walker, J. J., Machin, S. J., Barrowcliffe, T., Greaves, M., Ludlam, C. A., Mackie, I. J., et al. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.6.489 · Cited by 42
Cited by
ESC Guidelines on the management of cardiovascular diseases during pregnancy
Endorsed by the European Society of Gynecology (ESG), T. A. F. E. P. C. (., Authors/Task Force Members, Regitz-Zagrosek, V., Blomstrom Lundqvist, C., Borghi, C., Cifkova, R., Ferreira, R., Foidart, J.-M., Gibbs, J. S. R., Gohlke-Baerwolf, C., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr218 · Cited by 1,924
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Middeldorp, S., Veenstra, D. L., Prabulos, A.-M., & Vandvik, P. O. (2012) · Chest · doi:10.1378/chest.11-2300 · Cited by 1,525
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Greer, I. A., & Nelson-Piercy, C. (2005) · Blood · doi:10.1182/blood-2005-02-0626 · Cited by 797
Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Pabinger, I., Sofaer, S., & Hirsh, J. (2008) · Chest · doi:10.1378/chest.08-0761 · Cited by 793
Self-citation
Metadata
- Authors
- Brill-Edwards, P., Ginsberg, J. S., Gent, M., Hirsh, J., Burrows, R., Kearon, C., Geerts, W., Kovacs, M., Weitz, J. I., Robinson, K. S., Whittom, R., & Couture, G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2000-11-16
- Volume
- 343
- Issue
- 20
- Pages
- 1439-1444
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2339094875
- Cited by
- 388
- References
- 27
- FWCI
- 14.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.